Philip J. Lupo, PhD, MPH
- Cancer and Blood Disorders
Endowed Chair in Molecular Epidemiology, Texas Children's Hospital
Director, Epidemiology and Population Sciences Program, Texas Children's Cancer and Hematology Center
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Member, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Adjunct Associate Professor, Human Genetics Center, Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health
Departments:
Office location:
6620 Main St
Houston, TX 77030
Get to know Philip J. Lupo, PhD, MPH
Dr. Philip Lupo is a genetic epidemiologist with a focus on susceptibility to childhood cancer and congenital conditions. He is the Chair of the Children’s Oncology Group (COG) Epidemiology Committee and has served in various capacities in the National Birth Defects Prevention Network (NBDPN), including President and Chair of the Data Committee.
The ultimate goal of Dr. Lupo’s research is to discover factors that can be used in new prevention efforts and targeted interventions to limit the adverse consequences of pediatric diseases.
He has a particular interest in the use of novel epidemiologic study designs and methods in determining the etiologies of pediatric and perinatal conditions.
Dr. Lupo is also on the editorial board of several journals including Birth Defects Research, which is the official publication for the Society for Birth Defects Research and Prevention; Human Genetics and Genomics Advances (HGG Advances), which is affiliated with the American Society of Human Genetics (ASHG), Journal of National Cancer Institute Cancer Spectrum and Pediatric Blood Cancer.
Examples of his ongoing research include:
- the COG-supported Genetics of Embryonal and Alveolar Rhabdomyosarcoma Study (GEARS), where children diagnosed with rhabdomyosarcoma and their families are actively being enrolled throughout North America to better understand genetic susceptibility to this frequently fatal malignancy;
- the Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium, whose goal is to improve outcomes among Latino children diagnosed with acute leukemia;
- the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Study, a multistate collaboration evaluating the risk of cancer in children with birth defects; and
- the NIH-funded Genetic Epidemiology of Multiple Malformation Syndrome (GEMMS) Study, where Dr. Lupo and his colleagues are leveraging data from birth defects surveillance programs to identify novel multiple congenital anomaly syndromes.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| University of Texas Health Science Center | Post-doctoral Fellowship | Genetic Epidemiology | 2010 |
| University of Texas Health Science Center | PhD | Doctor of Philosophy, Epidemiology | 2009 |
| University of Texas Health Science Center | Masters | Master of Public Health, Disease Control | 2004 |
| Houston Baptist University | Bachelors | Bachelor of Science, Biology and Political Science | 1996 |
Organizations
| Organization Name | Role |
|---|---|
| American Association for Cancer Research (AACR) | Member |
| American Society of Human Genetics (ASHG) | Member |
| Childhood Cancer & Leukemia International Consortium (CLIC) | Member |
| Children’s Oncology Group (COG) | Member and Chair, Epidemiology Committee |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development Initial Review Group’s (IRG) | Member, Developmental Biology Study Section (CHHD) |
| International Society of Paediatric Oncology (SIOP) | Member |
| National Birth Defects Prevention Network | Member |
| National Cancer Institute (NCI) | Member, Cancer Prevention Steering Committee |
| Society for Birth Defects Research and Prevention | Vice President |
| Texas Cancer Registry (TCR) | Member, Advisory Committee |
Honors and awards
- 2021
-
Research Mentor Award, Baylor College of Medicine
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Spanning the Spectrum of Sarcoma Research at Texas Children’s Cancer and Hematology Center
Research Area:
Epidemiology (Cancer and Hematology)
Dr. Philip Lupo is a genetic epidemiologist with a focus on susceptibility to childhood cancer and congenital conditions. He is the Chair of the Children’s Oncology Group (COG) Epidemiology Committee and has served in various capacities in the National Birth Defects Prevention Network (NBDPN), including President and Chair of the Data Committee.
The ultimate goal of Dr. Lupo’s research is to discover factors that can be used in new prevention efforts and targeted interventions to limit the adverse consequences of pediatric diseases.
He has a particular interest in the use of novel epidemiologic study designs and methods in determining the etiologies of pediatric and perinatal conditions.
Dr. Lupo is also on the editorial board of several journals including Birth Defects Research, which is the official publication for the Society for Birth Defects Research and Prevention; Human Genetics and Genomics Advances (HGG Advances), which is affiliated with the American Society of Human Genetics (ASHG), Journal of National Cancer Institute Cancer Spectrum and Pediatric Blood Cancer.
Examples of his ongoing research include:
- the COG-supported Genetics of Embryonal and Alveolar Rhabdomyosarcoma Study (GEARS), where children diagnosed with rhabdomyosarcoma and their families are actively being enrolled throughout North America to better understand genetic susceptibility to this frequently fatal malignancy;
- the Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium, whose goal is to improve outcomes among Latino children diagnosed with acute leukemia;
- the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Study, a multistate collaboration evaluating the risk of cancer in children with birth defects; and
- the NIH-funded Genetic Epidemiology of Multiple Malformation Syndrome (GEMMS) Study, where Dr. Lupo and his colleagues are leveraging data from birth defects surveillance programs to identify novel multiple congenital anomaly syndromes.